CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40

被引:352
作者
Yang, YP
Wilson, JM
机构
[1] WISTAR INST ANAT & BIOL,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104
[2] UNIV PENN,MED CTR,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104
[3] UNIV PENN,MED CTR,DEPT MOL & CELLULAR ENGN,PHILADELPHIA,PA 19104
关键词
D O I
10.1126/science.273.5283.1862
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The role of CD40 ligand (CD40L) in the primary activation of T cells is not clear. The cellular and humoral immune responses to adenoviral vectors in a murine model of liver-directed gene transfer were studied to define the mechanisms responsible for CD40L-dependent T cell priming. CD40L-deficient mice did not develop effective cytotoxic T cells to transduced hepatocytes, and T cell-dependent B cell responses were absent. Full reconstitution of cellular and humoral immunity was achieved in CD40L-deficient mice by administration of an activating antibody to CD40 that increased expression of B7.2 on spleen cells. Wild-type mice could be made nonresponsive to vector by administration of antibodies to B7. Thus, CD40L-dependent activation of T cells occurs through signaling of CD40 in the antigen-presenting cell to enhance requisite costimulatory pathways that include B7.
引用
收藏
页码:1862 / 1864
页数:3
相关论文
共 24 条
[1]   CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME [J].
ALLEN, RC ;
ARMITAGE, RJ ;
CONLEY, ME ;
ROSENBLATT, H ;
JENKINS, NA ;
COPELAND, NG ;
BEDELL, MA ;
EDELHOFF, S ;
DISTECHE, CM ;
SIMONEAUX, DK ;
FANSLOW, WC ;
BELMONT, J ;
SPRIGGS, MK .
SCIENCE, 1993, 259 (5097) :990-993
[2]   THE YIN AND YANG OF T-CELL COSTIMULATION [J].
ALLISON, JP ;
KRUMMEL, MF .
SCIENCE, 1995, 270 (5238) :932-933
[3]   THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
ARUFFO, A ;
FARRINGTON, M ;
HOLLENBAUGH, D ;
LI, X ;
MILATOVICH, A ;
NONOYAMA, S ;
BAJORATH, J ;
GROSMAIRE, LS ;
STENKAMP, R ;
NEUBAUER, M ;
ROBERTS, RL ;
NOELLE, RJ ;
LEDBETTER, JA ;
FRANCKE, U ;
OCHS, HD .
CELL, 1993, 72 (02) :291-300
[4]   CD40 ligand is required for protective cell-mediated immunity to Leishmania major [J].
Campbell, KA ;
Ovendale, PJ ;
Kennedy, MK ;
Fanslow, WC ;
Reed, SG ;
Maliszewski, CR .
IMMUNITY, 1996, 4 (03) :283-289
[5]   CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION [J].
DAI, YF ;
SCHWARZ, EM ;
GU, DL ;
ZHANG, WW ;
SARVETNICK, N ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1401-1405
[6]   CD40 LIGAND MUTATIONS IN X-LINKED IMMUNODEFICIENCY WITH HYPER-IGM [J].
DISANTO, JP ;
BONNEFOY, JY ;
GAUCHAT, JF ;
FISCHER, A ;
DESAINTBASILE, G .
NATURE, 1993, 361 (6412) :541-543
[7]   IMPAIRMENT OF ANTIGEN-SPECIFIC T-CELL PRIMING IN MICE LACKING CD40 LIGAND [J].
GREWAL, IS ;
XU, JC ;
FLAVELL, RA .
NATURE, 1995, 378 (6557) :617-620
[8]   PROPERTIES OF MOUSE CD40 - CELLULAR-DISTRIBUTION OF CD40 AND B-CELL ACTIVATION BY MONOCLONAL ANTI-MOUSE CD40 ANTIBODIES [J].
HASBOLD, J ;
JOHNSONLEGER, C ;
ATKINS, CJ ;
CLARK, EA ;
KLAUS, GGB .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (08) :1835-1842
[9]   Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity [J].
Kamanaka, M ;
Yu, P ;
Yasui, T ;
Yoshida, K ;
Kawabe, T ;
Horii, T ;
Kishimoto, T ;
Kikutani, H .
IMMUNITY, 1996, 4 (03) :275-281
[10]   LONG-TERM HEPATIC ADENOVIRUS-MEDIATED GENE-EXPRESSION IN MICE FOLLOWING CTLA4LG ADMINISTRATION [J].
KAY, MA ;
HOLTERMAN, AX ;
MEUSE, L ;
GOWN, A ;
OCHS, HD ;
LINSLEY, PS ;
WILSON, CB .
NATURE GENETICS, 1995, 11 (02) :191-197